The chemist associations are protesting the FDA's crackdown on chemists operating without qualified pharmacists. There are around 55,000 chemists in Maharashtra of which 7,000 operate in Mumbai.
Chemists are now agitating against the Maharashtra FDA new rule, under which the patients will have to get new prescription every time they visit a chemist shop to purchase regularly used medicines, to be taken for life time diseases like asthma, blood pressure, diabetes, arthritis etc.
FDA had asked chemists to sell medicines on prescription that fall under the schedules prescribed by the Centre.
The patient will have to get the prescription only from qualified allopathic doctor to get allopathic medicine. The people from the slum and interior areas will suffer most as there are hardly any allopathic doctors practising in the said areas, the Retail & Dispensing Chemists Association said in a statement here.
In rural areas, the problem will be more pronounced as in a radius of 20 kms there are hardly any qualified doctors, the release said.
But, according to Maharashtra FDA, the law has to be followed even at the cost of the patient's life, which may drastically affect the health care system of the society, the association said.
If the FDA doesn't stop implementing the law in a "draconian" way without looking into practicality, the chemists will be forced to go on an indefinite strike, it said.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
